Certain genetic variant in Alzheimer’s disease linked to African ancestry
Feb 22, 2023
An increased risk for Alzheimer’s disease and younger age of onset were seen with the APOE ε3 R145C missense variation.
Prevalence of LATE-NC explored in seniors, Alzheimer’s disease
Jun 20, 2022
Almost 40% of those with Alzheimer’s disease neuropathologic change had a limbic-predominant age-related TDP-43 encephalopathy neuropathologic change.
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.
Senior living community will ‘vigorously’ defend itself in wrongful termination lawsuit
By
Kimberly Bonvissuto
Jun 02, 2022
The owner of an Iowa assisted living and memory care community says the company will “vigorously” defend itself in a wrongful termination lawsuit from a former resident assistant who alleges she was...
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
New CDC profile shares demographics of assisted living residents
By
Kimberly Bonvissuto
Sep 22, 2021
Bathing, walking and dressing are the most common activities of daily living that residents of assisted living or similar residential communities need help with, according to a new data brief from the...
More news for Wednesday, Jan. 4
By
Kimberly Bonvissuto
Jan 04, 2023
$10K reward offered for info about murders of assisted living couple … SC health department takes emergency action against 4 assisted living communities … Grant provides memory care training for senior...
FDA head asks for investigation into Alzheimer’s disease drug approval
Jul 12, 2021
The request follows reports that Biogen and the FDA held off-the-books meetings before the drug’s approval that may have violated FDA protocol.
Prediction model for brain age may help detect cognitive decline
Jul 01, 2021
Greater differences between predicted age based on brain MRI and actual age were seen in those with amnestic mild cognitive impairment versus healthy controls.
Lilly to seek FDA approval for new drug for Alzheimer’s disease
Jun 25, 2021
Donanemab already has received a ‘breakthrough therapy’ designation from the FDA.